Q: According to media reports, the Chinese vaccines for COVID-19 are priced much higher than those of European and American ones. I wonder if you could comment on this?

A：This is a baseless claim. China is accelerating vaccine R&D to tackle COVID-19 situation. We announced that COVID-19 vaccine development and deployment in China, when available, will be made a global public good that helps to ensure vaccine accessibility and affordability in developing countries. Our commitment is clear and we will act on our words. As vaccines are still being developed across the world, there is great uncertainty in their future pricing. However, for China, one thing is certain: we will definitely provide the vaccines to the world as a global public good with fair and reasonable prices. Developing countries will be our priority in this process. We will provide the vaccines to them through various means, including donation and assistance.